Clinical trial
Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With…
NCT00265863 · Masonic Cancer Center, University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00265863 |
|---|---|
| Title | Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites |
| Official title | Phase II Study of Laparoscopic Hyperthermic Peritoneal Chemotherapy for Malignant Ascites |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Cancer |
| Intervention type | Drug |
| Interventions | mitomycin C |
| Enrollment | 1 |
| Start date | Aug 1, 2004 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Dec 15, 2005 |
| Last update posted | Nov 29, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: